Sandoz to give insight on European biosimilar trends at 7th Annual Congress

SMi Group are delighted to announce a new speaker for the two day event which will gather a global audience of biosimilar drug makers and regulatory experts this autumn.

Dr Luis Borlido, Lab Head Characterization from Sandoz GmbH will join the un-rivalled line-up at the conference “Biosimilars Europe” when it returns to Central London for its 7th annual show.

The exclusive presentation entitled: Recent Trends in the Development of Biosimilars and Evaluation of Analytical Biosimilarity, will offer a compelling overview of critical assessment strategies. As well as giving insight into current advances in biosimilars, the keynote address will also explore QbD driven development, statistical similarity data evaluation, and challenges of equivalence testing.

The notable speaker panel will also feature:

• Dr Alok Sharma, Head, Bio-Analytical Development, Lupin Ltd
• Atanas Dimitrov, Head of Strategy & Portfolio Management, Merck Group
• Dr Niraj Chhaya, Risk Management, Boehringer Ingelheim GmbH
• Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health
• Huiguo Hu, General Manager of International Business, Shanghai CP Guojian Pharmaceutical Co Ltd
• Dr Alok Sharma, Head, Bio-Analytical Development, Lupin Ltd
• Joan O’Callaghan, Research Scientist for Regulatory Science Ireland, Health Products Regulatory Authority

A full programme and full speaker line-up is available online at www.biosimilars-europe.com

7th annual conference:
Biosimilars Europe
29 – 30 September 2016
Holiday Inn Kensington Forum, London UK
www.biosimilars-europe.com

Sponsored by Abzena and Schwegman Lundberg Woessner

Contact Information:

For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: [email protected]
To register for the conference, visit www.biosimilars-europe.com or contact Fateja Begum on
Tel: +44 (0)20 7827 6184 / Email: [email protected]
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / 
Email: [email protected]